FindTrial
Sign In

?Clinical Observation of Oral Pirfenidone in the Treatment of Stiff skin syndrome

?Clinical Observation of Oral Pirfenidone in the Treatment of Stiff skin syndrome

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600117147
Enrollment
Unknown
Registered
2026-01-20
Start date
2026-01-25
Completion date
Unknown
Last updated
2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stiff skin syndrome

Interventions

Experimental group:Oral Perfenidone

Sponsors

Beijing Childrens Hospital,Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
6 Years to 18 Years

Inclusion criteria

Inclusion criteria: 1.Patients aged 6 to 18 years who meet the clinical and pathological diagnostic criteria for Stiff skin syndrome

Exclusion criteria

Exclusion criteria: 1.Exclude scleroderma, connective tissue nevus, scleromyxedema, and lichen myxedematosus

Design outcomes

Primary

MeasureTime frame
Ultrasonic skin thickness;Ultrasonic skin elasticity;Axillary test;—

Secondary

MeasureTime frame
Skin lesion Area;—

Countries

China

Contacts

Public ContactJiaosheng Xu

Beijing Childrens Hospital,Capital Medical University

xujiaosheng@sina.com+86 10 5961 6884

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026